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necessarily mean there is only one
candidate gene. We do not know
whether SSH1, ARPC3, and SART3 are
involved in the same pathway, but
some papers suggest that SSH1 and
ARPC3 may be involved in the actin
cytoskeleton pathway (Welch et al.,
1997; Pollard et al., 2000; Volkmann
et al., 2001; Niwa et al., 2002; Pelham
and Chang, 2002).
As to the heterozygous C/A-peak
perhaps it is caused by the low-resolu-
tion online image referred to (Figure 1
which is reproduced here). We are not
sure whether the S63N mutation is
innocuous or not, but it should be
confirmed by experiments.
We sincerely thank the authors for
their attention to our research. The
conclusions in our papers may be not
perfect, but the data generated by the
experiment are valid.
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TO THE EDITOR
An Associate Editor with expertise in
the field reviewed the online publica-
tion in question, along with an inde-
pendent observer, and agrees with Dr
Zhang. In addition, the Editor reviewed
all figures associated with this publica-
tion, including those submitted for
review purposes and those published
online and in print, and the Editor
agrees with Dr Zhang. The Editor
appreciates the concern over the valid-
ity of original data published in the JID,
and considers this case closed.
Lowell A. Goldsmith
Editor
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TO THE EDITOR
Pachyonychia congenita is a rare
autosomal-dominant disorder of keratin
that was first described in 1685 (Leach-
man et al., 2005). Named by Jadassohn
and Lewandowsky in 1906, this syn-
drome is characterized by hypertrophic
nail dystrophy, focal palmoplantar
keratoderma, follicular keratoses, and
other ectodermal features varying
by subtype. It is now well known that
pachyonychia congenita type 1 (PC-1),
also known as Jadassohn–Lewandowsky
syndrome, is caused by mutations in
either keratin 6a (K6a) or keratin 16
(K16), whereas pachyonychia con-
genita type 2 (PC-2), also known as
Jackson–Lawler syndrome, is caused
by mutations in keratin 6b (K6b) or
its expression partner keratin 17 (K17)
(Munro, 2001). Both subtypes have
hypertrophic nail dystrophy and painful
plantar keratoderma as the most
significant clinical findings with fea-
tures such as natal teeth, steatocysts,
and hair abnormalities being more
common in PC-2 and oral leukokera-
tosis more common in pachyonychia
congenita type 1 (Leachman et al.,
2005).
The number of patients worldwide
that are believed to have PC is between
1,000 and 10,000 (Kaspar, 2005). There
have been more than 82 mutations
published in the literature thus far with
all established mutations consistent
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